14.49
3.33%
0.51
Schlusskurs vom Vortag:
$13.98
Offen:
$13.92
24-Stunden-Volumen:
149.97K
Relative Volume:
0.07
Marktkapitalisierung:
$1.19B
Einnahmen:
$1.13B
Nettoeinkommen (Verlust:
$62.75M
KGV:
29.57
EPS:
0.49
Netto-Cashflow:
$170.92M
1W Leistung:
+3.33%
1M Leistung:
-11.65%
6M Leistung:
-47.40%
1J Leistung:
-56.04%
Progyny Inc Stock (PGNY) Company Profile
Firmenname
Progyny Inc
Sektor
Branche
Telefon
212-888-3124
Adresse
1359 BROADWAY, NEW YORK, NY
Vergleichen Sie PGNY mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
PGNY | 14.51 | 1.19B | 1.13B | 62.75M | 170.92M | 0.49 |
VEEV | 213.88 | 33.92B | 2.57B | 615.26M | 996.76M | 3.32 |
SOLV | 69.22 | 11.55B | 8.25B | 404.00M | 1.52B | 0.00 |
DOCS | 49.77 | 9.32B | 493.63M | 160.55M | 162.20M | 0.55 |
TEM | 55.08 | 9.04B | 640.44M | -743.28M | -206.93M | 0.00 |
HQY | 103.11 | 8.87B | 1.10B | 105.67M | -197.98M | 0.1475 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-01-03 | Eingeleitet | Barclays | Overweight |
2023-09-27 | Eingeleitet | Canaccord Genuity | Buy |
2023-05-22 | Eingeleitet | BTIG Research | Buy |
2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
2023-01-05 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2022-09-07 | Eingeleitet | Truist | Buy |
2021-12-02 | Eingeleitet | Jefferies | Buy |
2021-11-22 | Herabstufung | Citigroup | Buy → Neutral |
2021-09-30 | Eingeleitet | Berenberg | Buy |
2021-08-12 | Eingeleitet | Barclays | Overweight |
2021-06-02 | Herabstufung | Guggenheim | Buy → Neutral |
2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
2020-06-02 | Eingeleitet | Guggenheim | Buy |
2019-11-19 | Eingeleitet | Citigroup | Buy |
2019-11-19 | Eingeleitet | Goldman | Buy |
2019-11-19 | Eingeleitet | JP Morgan | Overweight |
2019-11-19 | Eingeleitet | Piper Jaffray | Overweight |
2019-11-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Progyny Inc Aktie (PGNY) Neueste Nachrichten
76,350 Shares in Progyny, Inc. (NASDAQ:PGNY) Purchased by Aurora Investment Counsel - MarketBeat
Progyny's (NASDAQ:PGNY) Solid Earnings Have Been Accounted For Conservatively - Simply Wall St
How To Trade (PGNY) - Stock Traders Daily
Johnson Fistel has Commenced an Investigation on Behalf of Progyny (PGNY) Shareholders - GlobeNewswire
Here’s Why Progyny (PGNY) Was Under Pressure in Q3 - Yahoo Finance
Progyny: After A Terrible Year, I'm Out (Rating Downgrade) - Seeking Alpha
Progyny (NASDAQ:PGNY) Hits New 1-Year Low Following Analyst Downgrade - MarketBeat
Entropy Technologies LP Invests $761,000 in Progyny, Inc. (NASDAQ:PGNY) - MarketBeat
Progyny, Inc. (NASDAQ:PGNY) Given Average Rating of "Hold" by Brokerages - MarketBeat
Truist Securities Downgrades Progyny (PGNY) - MSN
Progyny (PGNY) Tops Q3 Earnings Estimates - MSN
Progyny, Inc. to Present at Jefferies London Healthcare Conference - The Manila Times
Barclays Lowers Progyny (NASDAQ:PGNY) Price Target to $17.00 - MarketBeat
Progyny CEO to Present at Jefferies London Healthcare Conference in 2024 | PGNY Stock News - StockTitan
Progyny Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Progyny price target lowered to $21 from $22 at BofA - Yahoo Finance
Progyny price target lowered to $17 from $30 at Barclays - TipRanks
88,527 Shares in Progyny, Inc. (NASDAQ:PGNY) Bought by GSA Capital Partners LLP - MarketBeat
Why Progyny Stock Crashed Today - AOL
Progyny stock hits 52-week low at $13.93 amid market shifts - Investing.com Australia
Progyny (PGNY) Stock Drops: Key Factors Behind Today's Movement - GuruFocus.com
Progyny stock plunges 18% amid lowered guidance, Truist downgrade - MSN
Jefferies cuts Progyny target to $19, maintains buy rating By Investing.com - Investing.com UK
Progyny price target lowered to $19 from $24 at Jefferies - TipRanks
Progyny, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2024 - Marketscreener.com
Progyny stock plunges 18% amid lowered guidance, Truist downgrade (NASDAQ:PGNY) - Seeking Alpha
Progyny (NASDAQ:PGNY) Shares Gap Down After Earnings Miss - MarketBeat
500: Something went wrong - Investing.com India
These Analysts Slash Their Forecasts On Progyny Following Q3 Results - Benzinga
Earnings call: Progyny, Inc. sees modest revenue growth and client expansion - Investing.com
Canaccord Genuity Group Has Lowered Expectations for Progyny (NASDAQ:PGNY) Stock Price - MarketBeat
Progyny (NASDAQ:PGNY) Posts Earnings Results, Misses Expectations By $0.26 EPS - MarketBeat
A Closer Look at 11 Analyst Recommendations For Progyny - Benzinga
Cantor cuts Progyny shares target, holds overweight rating on revised estimates - Investing.com Nigeria
Truist Financial Reiterates "Hold" Rating for Progyny (NASDAQ:PGNY) - MarketBeat
Progyny, Inc. (NASDAQ:PGNY) Q3 2024 Earnings Call Transcript - Insider Monkey
Progyny price target lowered to $17 from $18 at Canaccord - TipRanks
Progyny downgraded to Hold from Buy at Truist - TipRanks
Progyny Inc (PGNY) Q3 2024 Earnings Call Highlights: Strong Clie - GuruFocus.com
Progyny earnings beat by $0.26, revenue fell short of estimates - Investing.com Canada
Progyny stock under pressure as Truist flags missed targets and soft consumption - Investing.com
Progyny Inc (PGNY) Q3 2024 Earnings Call Highlights: Strong Client Growth Amid Utilization ... - Yahoo Finance
Progyny: Q3 Earnings Snapshot - The Washington Post
Progyny, Inc. Reports Steady Growth Amid Strategic Wins - TipRanks
Progyny, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Stocks to Watch: Spirit Airlines, Rocket Lab, Progyny - MarketWatch
Progyny Shares Fall Following Weak 3Q, Lowered FY Outlook - MarketWatch
Progyny Inc Q3 2024 Earnings: EPS of $0.11 Misses Estimates, Rev - GuruFocus.com
Progyny, Inc. Announces Third Quarter 2024 Results - The Manila Times
Progyny Q3 Revenue Grows 2% to $286.6M, Adds 80+ Clients Despite Treatment Delays | PGNY Stock News - StockTitan
Progyny's (NASDAQ:PGNY) earnings trajectory could turn positive as the stock hikes 11% this past week - Simply Wall St
Finanzdaten der Progyny Inc-Aktie (PGNY)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):